References
1. Andrew, M.D. Neuroblastoma J Seminars in pediatric surgery.2012 , 21, 2-14.
2. Md Kamrul, H.; Asmaa, N.; Atsushi, T.; Satoshi, K.; Miki, O.; Yusuke, S.; Shamim, H.; Jesmin, A.; Atsushi, O.; Yohko, N.; et al. ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma J Scientific reports. 2013 , 3, 3450.
3. Park, J.R.; Kreissman, S.G.; London, W.B. Effect of tandem autologous stem cell transplant vs single transplant on event-free survival in patients with high-risk neuroblastoma: a randomized clinical trial. JAMA. 2019 , 322, 746-755.
4. Cohn, S.L.; Pearson, A.D.J.; London, W.B.; Monclair, T.; Pete, r.F.A.; Garrett, M.B.; Andreas, F.; Barbara, H.; Tomoko, I.; David, M.; et al. The International Neuroblastoma Risk Group (INRG) classification system: An INRG task force report. J Journal of clinical oncology : official journal of the American Society of Clinical Oncology.2009 , 27, 289-297.
5. Brodeur; Kojima, M.; BagatellRochelle Mechanisms of neuroblastoma regression. J Nature Reviews Clinical Oncology. 2014 , 11, 704-713.
6. Morgenstern, D.A.; Baruchel, S.Irwin, M.S. Current and future strategies for relapsed neuroblastoma: Challenges on the road to precision therapy. J Journal of Pediatric Hematology/Oncology.2013 , 35, 337-347.
7. Cole, K.A.Maris, J.M. New strategies in refractory and recurrent neuroblastoma: Translational opportunities to impact patient outcome J Clinical Cancer Research. 2012 , 18, 2423-2428.
8. Simon, M.; Berthold, F.; Borkhardt, A.; Kremens, B.; Carolis, B.D.Hero, B. Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials. J Pediatr Blood Cancer.2011 , 56, 578-583.
9. Smith, M.A.; Seibel, N.L.; Altekruse, S.F.; Ries, L.A.G.; Melbert, D.L.; Leary, M.L.; Smith, F.O.Reaman, G.H. Outcomes for children and adolescents with cancer: challenges for the twenty-first century.J Journal of Clinical Oncology. 2010 , 28, 2625-2634.
10. Matthay, K.K.; Reynolds, C.P.; Seeger, R.C.; Shimada, H.; Adkins, E.S.; Haas-Kogan, D.; Gerbing, R.B.; London, W.B.Villablanca, J.G. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A children’s oncology group study. J Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 , 27, 1007-1013.
11. Garaventa, A.; Parodi, S.; Bernardi, B.D.; Dau, D.; Manzitti, C.; Conte, M.; Casale, F.; Viscardi, E.; Bianchi, M.Angelo, D. Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry. J European Journal of Cancer. 2009 , 45, 2835-2842.
12. John, M.M.; Hogarty, M.D.; Rochelle, B.Cohn, S.L. Neuroblastoma J The Lancet. 2007 , 369, 2106-2120.
13. M. Schwab; Ellison, J.; Busch, M.; Rosenau, W.; Varmus, H.E.Bishop, J.M. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. J Proc. Natl. Acad. Sci. U. S. A. 1984 , 81, 4940-4944.
14. MarisJohn, M.M.D. Recent advances in neuroblastoma. J New England Journal of Medicine. 2010 , 362, 2202-2211,2154.
15. Brodeur, G.M.; Seeger, R.C.; Schwab, M.; Varmus, H.E.Bishop, J.M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage J Science. 1984 , 224, 1121-1124.
16. Marshall, G.M.; Carter, D.R.; Cheung, B.B.; Liu, T.; Mateos, V.; Meyerowitz, J.G.Weiss, W.A. The prenatal origins of cancer J NATURE REVIEWS CANCER. 2014 , 14, 277-289.
17. Rickman, D.S.; Schulte, J.H.Eilers, M. The expanding world of N-MYC-driven tumors J Cancer Discovery. 2018 , 8, 150-163.
18. Johnsen, J.I.; Dyberg, C.Wickstrm, M. Neuroblastoma-A Neural Crest Derived Embryonal Malignancy. J Frontiers in molecular neuroscience. 2019 , 12, 9.
19. Huang, M.Weiss, W.A. Neuroblastoma and MYCN. J Cold Spring Harbor perspectives in medicine. 2013 , 3, a014415.
20. RC, S. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma J N Engl J Med. 1985 , 18, 1111-1116.
21. Wan; Jonathan, C.M.; Massie; Charles; Garcia-CorbachoJavier Liquid biopsies come of age: towards implementation of circulating tumour DNA J NATURE REVIEWS CANCER. 2017 , 17, 223-238.
22. Qureshi, S.S.; Bhagat, M.; Harris, C.; Chinnaswamy, G.; Vora, T.; Kembhavi, S.; Prasad, M.; Ramadwar, M.; Shetty, O.; Laskar, S.; et al. Outcomes and complications of surgery in patients with intermediate-risk neuroblastoma: experience from an Indian tertiary Cancer Centre.J Pediatric Surgery International. 2018 , 34, 435-442.
23. Marrano, P.; Irwin, M.S.Thorner, P.S. Heterogeneity of MYCN amplification in neuroblastoma at diagnosis, treatment, relapse, and metastasis. J Genes Chromosomes and Cancer. 2017 , 56, 28-41.
24. Kojima, M.; Hiyama, E.; FukubaI.; Yamaoka, E.; Ueda, Y.; Onitake, Y.; Kurihara, S.Sueda, T. Detection of MYCN amplification using blood plasma: Noninvasive therapy evaluation and prediction of prognosis in neuroblastoma. J Pediatric Surgery International. 2013 , 29, 1139-1145.
25. Berbegall, A.P.; Baruchel, S.Noguera, R. Diagnostic implications of intrapatient genetic tumor heterogeneity. Molecular and Cellular Oncology. 2016 , 3, e1079671.
26. Bogen, D.; Brunner, C.; Walder, D.; Ziegler, A.; Abbasi, R.; Ladenstein, R.L.; Noguera, R.; Martinsson, T.; Amann, G.; Schilling, F.H.; et al. The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma J International Journal Of Cancer. 2016 , 139, 153-163.
27. Iehara, T.; Yagyu, S.; Gotoh, T.; Yoshida, H.; Miyachi, M.; Kikuchi, K.; Sugimoto, T.Hosoi, H. A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patients. J Japanese journal of clinical oncology. 2019 , 49, 743-748.
28. Ma, Y.; Lee, J.W.; Park, J.R.; Yi, E.S.; Choi, Y.B.; Yoo, K.H.; Sung, K.W.Koo, H.H. Detection of MYCN amplification in serum DNA using conventional polymerase chain reaction. J Journal of Korean Medical Science. 2016 , 31, 1392-1396.
29. Combaret, V.; Hogarty, M.D.; London, W.B.; McGrady, P.; Iacono, I.; Brejon, S.; Swerts, K.; Noguera, R.; Gross, N.; Rousseau, R.; et al. Influence of neuroblastoma stage on serum-based detection of MYCN amplification J Pediatric blood & cancer. 2009 , 53, 329-331.
30. Gotoh, T.; Hosoi, H.; Iehara, T.; Kuwahara, Y.; Osone, S.; Tsuchiya, K.; Ohira, M.; Nakagawara, A.; Kuroda, H.; Sugimoto, T. Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. J Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 , 23, 5205-5210.